Class II · Moderate risk
1% Clotrimazol cream
CGMP Deviations
VERMOX Tablets 500 mg
Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.
Why it was recalled
CGMP Deviations
Cause type: cGMP deviation
Departures from current Good Manufacturing Practice found in production or during FDA inspection. A broad quality-system cause: the batch was made under conditions that fall short of FDA manufacturing standards. All cgmp deviation recalls.
What was recalled
VERMOX Tablets 500 mg, 1-count box, UPC 501109900596
- Recalling firm
- Profarma Distributors LLC
- Origin
- OH, United States
- Initiated by
- Voluntary: Firm initiated
- FDA recall number
- D-1042-2016 · FDA notice
Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.
Other recalls by Profarma Distributors LLC
All 2016 recalls
Class II · Moderate risk
VERMOX Tablets 100 mg
CGMP Deviations
Class II · Moderate risk
tabcin NOCHE
CGMP Deviations
Class II · Moderate risk
tabcin ACTIVE M.R. Capsules
CGMP Deviations
Other cgmp deviation recalls from 2016
All cgmp deviation recalls
Class II · Moderate risk
Gentell Hydrogel Wound Dressing REGULAR
CGMP Deviations
Class II · Moderate risk
Gentell Hydrogel Ag Saturated Gauze
CGMP Deviations
Class II · Moderate risk
Torsemide Tablets
CGMP Deviations
Class II · Moderate risk
Torsemide Tablets
CGMP Deviations
Free recall alerts
Know the day your medication is recalled
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.